Goodwin Procter advised Disc Medicine, while Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the offering. Disc Medicine (NASDAQ: IRON) announced its upsized underwritten...
Disc Medicine’s $259.3 Million Follow-on Offering
Alnylam Pharmaceuticals’ $1.035 Billion Notes Offering
Goodwin Procter advised Alnylam Pharmaceuticals, Inc. on the deal, while Davis Polk advised the representative of the initial purchasers. Alnylam Pharmaceuticals, Inc. announced its inaugural offering...